CAS 51781-21-6: Carteolol hydrochloride
Description:Carteolol hydrochloride is a non-selective beta-adrenergic antagonist primarily used in the treatment of glaucoma and ocular hypertension. As a member of the beta-blocker class, it works by reducing intraocular pressure through decreased aqueous humor production. The substance appears as a white to off-white crystalline powder, which is soluble in water and exhibits a pKa indicative of its basic nature. Its molecular formula reflects a complex structure that includes a phenolic moiety, contributing to its pharmacological activity. Carteolol hydrochloride is characterized by its ability to penetrate the cornea, making it effective for topical ophthalmic use. Additionally, it may possess intrinsic sympathomimetic activity, which can lead to fewer side effects compared to other beta-blockers. The compound is typically administered as an eye drop solution, and its efficacy is often evaluated in clinical settings for managing elevated intraocular pressure. As with any medication, potential side effects and contraindications should be considered, and it is essential to follow medical guidance when using this substance.
Formula:C16H24N2O3·ClH
InChI:InChI=1S/C16H24N2O3.ClH/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13;/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20);1H
InChI key:InChIKey=FYBXRCFPOTXTJF-UHFFFAOYSA-N
SMILES:Cl.O=C1NC=2C=CC=C(OCC(O)CNC(C)(C)C)C2CC1
- Synonyms:
- 2(1H)-Quinolinone, 5-[3-[(1,1-Dimethylethyl)Amino]-2-Hydroxypropoxy]-3,4-Dihydro-, Monohydrochloride
- 2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-, hydrochloride (1:1)
- 5-(3-tert-Butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride
- 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydroquinolin-2(1H)-one hydrochloride (1:1)
- Arteoptic
- Caltidren
- Carteol
- Cartrol
- Endak
- Mikelan
- See more synonyms
- NSC 300906
- Oc 1085
- Ocupress
- Opc 1085
- Optipress
- Tenalet
- Tenalin
- Teoptic
- carteolol HCl
- dl-Carteolol hydrochloride
